scispace - formally typeset
M

Massimo Donadelli

Researcher at University of Verona

Publications -  96
Citations -  10208

Massimo Donadelli is an academic researcher from University of Verona. The author has contributed to research in topics: Cancer cell & Cancer. The author has an hindex of 35, co-authored 89 publications receiving 8125 citations. Previous affiliations of Massimo Donadelli include Vision-Sciences, Inc. & Academy of Sciences of the Czech Republic.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism

TL;DR: Findings support a key role of the ROS-dependent activation of an autophagic program in the synergistic growth inhibition induced by GEM/cannabinoid combination in human pancreatic cancer cells.
Journal ArticleDOI

Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.

TL;DR: A potent anti-tumour activity of TSA/GEM combination against pancreatic cancer cells in vitro and in vivo is demonstrated, strongly supporting the use of GEM in combination with an HDAC inhibitor for pancreaticcancer therapy.
Journal ArticleDOI

UCP2, a mitochondrial protein regulated at multiple levels

TL;DR: Novel findings concerning events that can occur in a concerted manner at various levels of UCP2 regulation are described: Ucp2 gene mutation (single nucleotide polymorphisms), U CP2 mRNA and protein expression (transcriptional, translational, and protein turn-over regulation), UCP1 proton conductance (ligands and post-transcriptionAL modifications), and nutritional and pharmacological regulation of U CP1.